'Sarcoma patients' diaporamas de présentation

The PI3K-AKT-mTOR pathway regulates cell growth, proliferation and metabolism in sarcoma

S. P. Chawla, J. Y. Blay, I. Ray-Coquard, A. Le Cesne, A. P. Staddon, M. M. Milhem, N. Penel, R. F. Riedel, B. Bui Nguyen, L. D. Cranmer, P. Reichardt, E. Bompas, Y. Song, R. M. Lee, J. E. Eid, J. Loewy, F. G. Haluska, P. F. Dodion, G. D. Demetri, on behalf of all SUCCEED investigators.

341 views • 23 slides

Factors Influencing Sarcoma Referral and Treatment

335 views • 23 slides

STATISTICAL RISK ANLAYSIS FOR CLINICAL OUTCOMES USING MID-THERAPY FDG PET IN SARCOMA PATIENTS

Janet Eary 1 , Janet O'Sullivan 3 , Finbarr O'Sullivan 3 , E. U. Conrad 2 1. Nuclear Medicine/Radiology, University of Washington, Seattle, WA, United States. 2. Orthopedics, University of Washington, Seattle, WA, United States. 3. Statistics, University College Cork, Cork, Ireland.

350 views • 21 slides

Efficacy and Safety of Conatumumab Plus AMG 479 in Patients With Advanced Sarcoma

Efficacy and Safety of Conatumumab Plus AMG 479 in Patients With Advanced Sarcoma. S Chawla, 1 AC Lockhart, 2 N Azad, 3 E Elez, 4 F Galimi, 5 N Baker, 6 YJ Hei, 5 H Kindler 7. 1 Sarcoma Oncology Center, Santa Monica, CA, USA

177 views • 17 slides

254 views • 12 slides

Anthony Tolcher Director of Clinical Research Institute for Drug Development CTRC, San Antonio TX

264 views • 11 slides

Anthony Tolcher Director of Clinical Research Institute for Drug Development CTRC, San Antonio TX

197 views • 11 slides

METHODS

A PHASE II STUDY OF NANOPARTICLE ALBUMIN-BOUND (NAB) PACLITAXEL IN THE TREATMENT OF PATIENTS WITH UNRESECTABLE OR METASTATIC SARCOMA. James E. Butrynski 1 , Rangarajan Nadadur 2 , Thierry Jahan 3 , Victoria Chua 4 , Claire Bautista Lazaro 4 , Sant Chawla 4.

144 views • 1 slides